Genpharmasec (531592)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2.29 |
| Market Cap | ₹128.69 Cr |
| P/E Ratio | 0 |
| ROCE | 3.35% |
| ROE | 4.38% |
| Dividend Yield | 0% |
| Profit Growth | -209.21% |
| Debt/Equity | — |
| Sales Growth | 369.69% |
| 52-Week Range | ₹0.76 — ₹2.29 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹1.27 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹2.29, Genpharmasec has a market cap of ₹129 crore. When I see sales growth of 369.69%, my attention is piqued, but a value investor must look through the windshield, not the rearview mirror. The latest quarter shows ₹40 crore in sales, yet the company lost ₹1 crore. Profit growth is down 209.21%, and the P/E is effectively zero—not because earnings are magnificent, but because earnings are absent. This is a trading and distribution business, an industry with inherently thin moats and limited pricing power. There is no evidence of durable competitive advantage.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer